Demand generation vs lead generation in biotech and life sciences
You're in biotech and life sciences, and your pipeline is full of names but empty of deals. That's the difference between demand generation and lead generation.
You're in biotech and life sciences, spending on lead generation. Forms are filled, but nobody picks up. The pipeline is full of contacts, empty of deals. Investors, partners, and customers each need their own version of your story. A list of names can't deliver that.
Lead generation gives you a list. In biotech and life sciences, that list often includes curious researchers who will never buy, or investors who found the wrong page. Your company speaks to three audiences at once: investors, partners, and customers. Each needs a clear, separate reason to trust your science. Generic lead magnets pull in the wrong crowd. Demand generation starts with brand clarity, so the right people show up ready to talk.
Demand generation for biotech isn't a faster lead form. It's a process of making your science clear to three different audiences. The scope depends on how many audiences you serve, how complex your science is, and whether your positioning already works for investors, partners, and customers. If your pitch deck says one thing and your website says another, the work starts there.
Stop buying leads that go nowhere. This week, look at your website. Does it have a page for investors that matches your pitch deck? One for partners that spells out the opportunity? One for customers that explains your science in plain terms? If not, fix that before another dollar goes to lead forms. I help biotech CEOs build demand generation that makes the right people call you. You don't get an account manager, you get me, and SliiceXR's execution behind the strategy.
When demand generation works, your pipeline fills with people who already believe in your science. Investors see the story they need. Partners understand the fit. Customers trust your claims because they're clear and substantiated. You stop chasing and start choosing.
What our customers say
"I have had the pleasure of working with Catherine and SLIICE Marketing for the last 8 months, I have found her to be smart, hardworking, and very knowledgeable. Catherine is professional and easy to work with, she understands marketing, branding, and how to put her clients in a winning position. I encourage you to have a discussion with her."
"Catherine was instrumental in establishing our website. Of greater import, she greatly aided us in gaining market awareness and capitalizing on the market recognition we already had. Besides the website, Catherine hosted a weekly podcast wherein we shared our views and insights regarding significant developments in our industry and their short- and long-term implications for our business and our clients."
"A few years ago I had the privilege of working with Catherine Oaks in the early stages of her Company, Image Base International. She is an inspiration. I love the way that she expresses her optimistic approach to any situation. Good or bad, Catherine just goes after it with a "Can Do" attitude. However, I think her greatest strength is her creativity. When we worked together, she always had an innovative, creative solution to any circumstance."
Other questions about demand generation for biotech and life sciences
why are our leads not qualified
Unqualified leads come from unclear positioning and a campaign built for volume. Decide exactly who you are for, say it plainly, and measure marketing on opportunities, not form fills.
brand to demand
It means the brand does the pre-selling so demand programs cost less and convert better. I connect the two: position first, then campaigns that turn recognition into qualified opportunities.
Ready to talk?
Ask SliiceXR about demand generation for biotech and life sciences.